Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2020; Elsevier BV; Volume: 396; Issue: 10246 Linguagem: Inglês
10.1016/s0140-6736(20)30732-7
ISSN1474-547X
AutoresEric L. Simpson, Rodney Sinclair, Seth Forman, Andreas Wollenberg, Roland Aschoff, Michael J. Cork, Thomas Bieber, Jacob P. Thyssen, Gil Yosipovitch, Carsten Flohr, Nina Magnolo, Catherine Maari, Claire Feeney, Pinaki Biswas, Svitlana Tatulych, Hernán Valdez, Ricardo Rojo,
Tópico(s)Asthma and respiratory diseases
Referência(s)